Home FDA labels 68adc464-5eb3-48bb-a0e6-e101ba9edd72 FDA label 68adc464-5eb3-48bb-a0e6-e101ba9edd72 openFDA label record# This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
SPL set ID 71067c14-2a02-47cc-95b7-b9f62ea8066c
SPL ID 68adc464-5eb3-48bb-a0e6-e101ba9edd72
Version 1
Effective date 2009-11-30
Source export date 2026-09-28
Source partition 12
Source file https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-09-28/663999d0fe1757c1e2cd13a4799d76d875f663e0bc57701092264ebe7febfc18/drug-label-0012-of-0014.json.zip
Source manifest SHA-256 cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run 20260929T050834Z
Imported at 2026-09-29 06:22:35 Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 2 matching rows.
Adverse reactions cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 1 · 1 matching rows.
adverse reactions ADVERSE REACTIONS In a case series of a limited number of patients who had been treated for up to 6 weeks with topically applied Nitric Oxide at 0.02% there were no reported adverse reactions. Adverse reactions reported by others to Nitric Oxide donating creams at concentrations of up to 3 times the recommended dose concentration of gaseous Nitric Oxide have included irritation and burning sensation of the skin around the wound.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.